News

Bassam Damaj, president and chief executive officer of NexMed, said: “Our Bio-Quant business has experienced continuous growth during the past five years, including an increase of over 20%

ChromoCure recently formed joint venture and technology sharing agreement with Genome Research Group, whose Therapeutic Modeling Protocols, together with ChromoCure’s Chromosomal Scanning Technology, further strengthens its leadership in

The product was manufactured in South Africa and is used for treatment of gout and hyperuricaemia. It can be sold in pharmacies under the supervision of a pharmacist.

Penwest’s TIMERx technology may be used for each compound selected. Penwest is expected to formulate the agreed-upon compounds and receive milestone and royalty payments that are linked to

Suven Life Sciences said that the granted claims of the patent include the class of selective serotonin receptor affinity compounds discovered by Suven and are being developed as

Sanofi Pasteur said that the core ETEC adhesin vaccine technology, developed by NMRC, was exclusively licensed to it, along with a second technology that efficiently packages the adhesin

Mederi said that the Stretta Therapy delivers radiofrequency (RF) energy to the muscles of the Lower esophageal sphincter (LES), the valve that separates the stomach from the esophagus.

The Hikal R&D Center in Bangalore provides process research of APIs, AIs and intermediates involving multi-step synthesis. Dr Ekkundi comes with over 26 years of experience in the

Cordis said that the Innovation trial (multicenter, open-label, prospective, non-randomized study of the Cordis AAA stent graft system in subjects with abdominal aortic aneurysm) is expected to enroll